Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis with bone mineral density (BMD) as the dependent variable, and sex, calendar age, body mass index (BMI), and grip strength as independent variables

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: The relationship between secondary sexual characteristics and bone mineral density (BMD). a Comparison of BMD between the “before change in voice” and “after change in voice” groups in boys. b Comparison of BMD between the “before menarche” and “after menarche” groups in girls. *p < 0.05, **p < 0.01

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques: Comparison

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Correlation between milk consumption and bone mineral density (BMD)

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis of bone mineral density (BMD) with intake of nutritional elements

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Environmental Health and Preventive Medicine

Article Title: Association between lifestyle habits and bone mineral density in Japanese juveniles

doi: 10.1007/s12199-009-0131-8

Figure Lengend Snippet: Multiple linear regression analysis of bone mineral density (BMD) with lifestyle and history of bone fracture

Article Snippet: BMD measurement BMD was measured by DXA at the distal forearm of the nondominant side (DTX-200; Osteometer MediTech Inc., CA, USA), as previously described [ 9 ].

Techniques:

Journal: Pediatric blood & cancer

Article Title: Modifying bone mineral density, physical function, and quality of life in children with acute lymphoblastic leukemia

doi: 10.1002/pbc.26929

Figure Lengend Snippet: Bone mineral density across time-points

Article Snippet: Height, weight, age, race and gender-adjusted corrected Z-scores constituted the BMD measures and were provided directly to us by Bioclinica.

Techniques:

Journal: JBMR Plus

Article Title: Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study

doi: 10.1002/jbm4.10346

Figure Lengend Snippet: Change in BMD relative to baseline during ACTIVE ( A baloparatide C omparator T rial I n V ertebral E ndpoints) for patients with type 2 diabetes mellitus (intent‐to‐treat population) mean percent change in BMD as measured using DXA at the ( A ) total hip, ( B ) femoral neck, and ( C ) lumbar spine in patients from ACTIVE with type 2 diabetes mellitus treated with placebo, abaloparatide, or teriparatide. Improvements in BMD were significantly greater ( p < 0.05) in the abaloparatide group versus the placebo group at all three sites and at all three time points, except for the femoral neck at 6 months. Improvements in BMD with teriparatide were significantly greater ( p < 0.05) versus those with placebo at all three sites and all three time points, except for total hip and femoral neck at 6 months. Error bars indicate 95% CIs. Missing BMD data were imputed using the method of last observation carried forward (LOCF). * P <0.001 ABL vs PBO; † P <0.05 ABL vs PBO; ‡ P <0.001 TPTD vs PBO; ¶ P <0.05 TPTD vs PBO. ABL, abaloparatide; BMD, bone mineral density; T2DM, type 2 diabetes mellitus; ITT, intent to treat; PBO, placebo; TPTD, teriparatide.

Article Snippet: Total hip, femoral neck, and lumbar spine BMD were assessed in the intent‐to‐treat (ITT) population at baseline and at months 6, 12, and 18 (BioClinica‐Synarc; Newark, CA, USA).

Techniques: